Acutus Medical Inc. (AFIB): Price and Financial Metrics
GET POWR RATINGS... FREE!
AFIB POWR Grades
- Growth is the dimension where AFIB ranks best; there it ranks ahead of 38.75% of US stocks.
- The strongest trend for AFIB is in Quality, which has been heading down over the past 31 weeks.
- AFIB ranks lowest in Sentiment; there it ranks in the 2nd percentile.
AFIB Stock Summary
- AFIB's went public 0.84 years ago, making it older than only 0.05% of listed US stocks we're tracking.
- AFIB's price/sales ratio is 44.1; that's higher than the P/S ratio of 94.11% of US stocks.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AFIB comes in at -36.18% -- higher than that of only 7.02% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Acutus Medical Inc are BIOL, KALA, DUO, OTRK, and VIVE.
- AFIB's SEC filings can be seen here. And to visit Acutus Medical Inc's official web site, go to www.acutusmedical.com.
AFIB Stock Price Chart Interactive Chart >
AFIB Price/Volume Stats
|Current price||$16.61||52-week high||$38.99|
|Prev. close||$16.67||52-week low||$11.18|
|Day high||$16.97||Avg. volume||325,228|
|50-day MA||$14.07||Dividend yield||N/A|
|200-day MA||$23.11||Market Cap||467.14M|
Acutus Medical Inc. (AFIB) Company Bio
Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists. Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, California. Its products are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.
AFIB Latest News Stream
|Loading, please wait...|
AFIB Latest Social Stream
View Full AFIB Social Stream
Latest AFIB News From Around the Web
Below are the latest news stories about Acutus Medical Inc that investors may wish to consider to help them evaluate AFIB as an investment opportunity.
CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will participate at the 41st Annual William Blair Growth Stock Conference on Thursday, June 3, 2021 at 12:20 p.m. Eastern Time. A live webcast of the presentation may be accessed by visiting ir.acutusmedical.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation. About Acutus MedicalAcutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is c...
Acutus Medical, Inc. (AFIB) Q1 2021 Earnings Conference Call May 12, 2021, 04:30 PM ET Company Participants Caroline Corner - Investor Relations Vince Burgess - President and Chief Executive Officer David Roman - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Margaret Kaczor - William Blair Bill Plovanic...
Acutus Medical (AFIB): Q1 Non-GAAP EPS of -$0.97 misses by $0.04; GAAP EPS of -$1.04 misses by $0.07.Revenue of $3.59M (+127.2% Y/Y) beats by $0.81M.Press Release...
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ: HOOK ) Novo Nordisk A/S (NYSE: NVO ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 11) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 4D pharma plc (NASDAQ: LBPS ) Acutus Medical, Inc. (NASDAQ: AFIB ) Adagene Inc. (NASDAQ: ADAG ) Adaptive Biotechnologies Corporation (NASDAQ: ADPT ) ADC Therapeutics SA (NYSE: ADCT ) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Akouos, Inc. (NASDAQ: AKUS ) (reacted to presentation of non-clinical data on gene therapy candidates at the American Society of Gene and Cell Therapy meeting) Akoya Biosciences, Inc. (NASDAQ: AKYA ) Ap...
Expanded and Product Portfolio Strengthens Offering in Access and Therapy Guidance AcQCross Transseptal Crossing Device Versatility to be utilized with top sheaths currently used in left atrium electrophysiology and structural heart procedures. Second Generation AcQGuide MAX Sheath These sheathes provide improved handling and deliverability to facilitate faster anatomy reconstruction. AcQMap Next Generation Mapping Catheter Integrated high-resolution ultrasound-based imaging and non-contact mapping catheter with improved torque response, handling, and maneuverability. CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announce...
AFIB Price Returns